Eva Rettinger

1.5k total citations
51 papers, 991 citations indexed

About

Eva Rettinger is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Eva Rettinger has authored 51 papers receiving a total of 991 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 28 papers in Oncology and 28 papers in Hematology. Recurrent topics in Eva Rettinger's work include Immune Cell Function and Interaction (30 papers), CAR-T cell therapy research (27 papers) and Hematopoietic Stem Cell Transplantation (27 papers). Eva Rettinger is often cited by papers focused on Immune Cell Function and Interaction (30 papers), CAR-T cell therapy research (27 papers) and Hematopoietic Stem Cell Transplantation (27 papers). Eva Rettinger collaborates with scholars based in Germany, United States and United Kingdom. Eva Rettinger's co-authors include Thomas Klingebiel, Peter Bader, Hermann Kreyenberg, André Willasch, Selim Kuçi, Sabine Huenecke, Peter Bader, Winfried S. Wels, Ulrike Koehl and Evelyn Ullrich and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Cancer.

In The Last Decade

Eva Rettinger

46 papers receiving 977 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva Rettinger Germany	19	547	518	321	147	138	51	991
Noriaki Yoshida Japan	20	372 0.7×	450 0.9×	295 0.9×	256 1.7×	130 0.9×	65	1.2k
Stephanie Schneider Germany	17	913 1.7×	1.1k 2.2×	383 1.2×	293 2.0×	140 1.0×	27	2.0k
Ellen Schrama Netherlands	15	324 0.6×	768 1.5×	401 1.2×	188 1.3×	315 2.3×	26	1.2k
Francesca Moretta Italy	22	719 1.3×	1.2k 2.3×	339 1.1×	182 1.2×	82 0.6×	36	1.7k
Pedro Horna United States	22	550 1.0×	721 1.4×	209 0.7×	252 1.7×	195 1.4×	73	1.5k
Darin Sumstad United States	13	436 0.8×	767 1.5×	528 1.6×	205 1.4×	269 1.9×	30	1.3k
Peter Bader Germany	27	846 1.5×	1.1k 2.0×	715 2.2×	231 1.6×	258 1.9×	76	1.9k
Aldemar Montero United States	11	324 0.6×	451 0.9×	552 1.7×	378 2.6×	92 0.7×	18	1.1k
John D. McMannis United States	18	420 0.8×	605 1.2×	900 2.8×	247 1.7×	270 2.0×	57	1.4k
Douglas Padley United States	18	568 1.0×	728 1.4×	446 1.4×	329 2.2×	211 1.5×	29	1.4k

Countries citing papers authored by Eva Rettinger

Since Specialization

Citations

This map shows the geographic impact of Eva Rettinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Rettinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Rettinger more than expected).

Fields of papers citing papers by Eva Rettinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Rettinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Rettinger. The network helps show where Eva Rettinger may publish in the future.

Co-authorship network of co-authors of Eva Rettinger

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Rettinger. A scholar is included among the top collaborators of Eva Rettinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Rettinger. Eva Rettinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jarisch, Andrea, André Willasch, Eva Rettinger, et al.. (2025). Case report: Advanced age at transplantation and pre-emptive treatment with dupilumab in DOCK8 deficiency. Frontiers in Immunology. 15. 1507494–1507494. 1 indexed citations

Sharma, Amit, Xiubao Ren, Antonio Rosato, et al.. (2024). Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy. Cancer Immunology Immunotherapy. 73(2). 21–21. 7 indexed citations

Rettinger, Eva, Martin Hutter, Peter Bader, et al.. (2024). Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia: Results of the AML BFM Study Group. Blood. 144(Supplement 1). 3548–3548.

Tonn, Torsten, et al.. (2024). Bortezomib promotes the TRAIL-mediated killing of resistant rhabdomyosarcoma by ErbB2/Her2-targeted CAR-NK-92 cells via DR5 upregulation. SHILAP Revista de lepidopterología. 32(2). 200802–200802. 2 indexed citations

Jarisch, Andrea, Emilia Salzmann‐Manrique, Jan Soerensen, et al.. (2023). Donor‐type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors. British Journal of Haematology. 201(6). 1159–1168.

Rettinger, Eva, et al.. (2022). Ruxolitinib als therapeutische Option bei progredientem Bronchiolitis obliterans Syndrom nach allogener Stammzelltransplantation. Klinische Pädiatrie. 234(5). 324–324.

Jarisch, Andrea, Eliza Wiercinska, Sabine Huenecke, et al.. (2022). Immune Responses to SARS-CoV-2 Vaccination in Young Patients with Anti-CD19 Chimeric Antigen Receptor T Cell-Induced B Cell Aplasia. Transplantation and Cellular Therapy. 28(7). 366.e1–366.e7. 11 indexed citations

Bremm, Melanie, Halvard Bönig, Richard Schäfer, et al.. (2021). Depletion of CD45RA+ T cells: Advantages and disadvantages of different purification methods. Journal of Immunological Methods. 492. 112960–112960. 2 indexed citations

Rettinger, Eva, Andrea Jarisch, Jan Tind Sørensen, et al.. (2020). Long‐term pulmonary function testing in pediatric bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Pediatric Pulmonology. 55(7). 1725–1735. 17 indexed citations

10.

Bremm, Melanie, Andrea Quaiser, Matthias Merker, et al.. (2019). Improving Clinical Manufacturing of IL-15 Activated Cytokine-Induced Killer (CIK) Cells. Frontiers in Immunology. 10. 1218–1218. 21 indexed citations

11.

Merker, Matthias, Emilia Salzmann‐Manrique, Sabine Huenecke, et al.. (2019). Clearance of Hematologic Malignancies by Allogeneic Cytokine-Induced Killer Cell or Donor Lymphocyte Infusions. Biology of Blood and Marrow Transplantation. 25(7). 1281–1292. 32 indexed citations

12.

Merker, Matthias, Michael T. Meister, Eva Rettinger, et al.. (2018). Haploidentical allogeneic hematopoietic stem cell transplantation in patients with high-risk soft tissue sarcomas: results of a single-center prospective trial. Bone Marrow Transplantation. 53(7). 891–894. 7 indexed citations

13.

Huenecke, Sabine, Melanie Bremm, Halvard Bönig, et al.. (2018). Epstein-Barr virus–specific cytokine-induced killer cells for treatment of Epstein-Barr virus–related malignant lymphoma. Cytotherapy. 20(6). 839–850. 7 indexed citations

14.

Bremm, Melanie, Sabine Huenecke, Andrea Quaiser, et al.. (2016). In-vitro influence of mycophenolate mofetil (MMF) and Ciclosporin A (CsA) on cytokine induced killer (CIK) cell immunotherapy. Journal of Translational Medicine. 14(1). 264–264. 8 indexed citations

15.

Willasch, André, Emilia Salzmann‐Manrique, Joerg Faber, et al.. (2016). Treatment of relapse after allogeneic stem cell transplantation in children and adolescents with ALL: the Frankfurt experience. Bone Marrow Transplantation. 52(2). 201–208. 18 indexed citations

16.

Rettinger, Eva, Hermann Kreyenberg, Matthias Merker, et al.. (2014). Immunomagnetic selection or irradiation eliminates alloreactive cells but also reduces anti-tumor potential of cytokine-induced killer cells: implications for unmanipulated cytokine-induced killer cell infusion. Cytotherapy. 16(6). 835–844. 20 indexed citations

17.

Willasch, André, Hermann Kreyenberg, Nona Shayegi, et al.. (2014). Monitoring of Hematopoietic Chimerism after Transplantation for Pediatric Myelodysplastic Syndrome: Real-Time or Conventional Short Tandem Repeat PCR in Peripheral Blood or Bone Marrow?. Biology of Blood and Marrow Transplantation. 20(12). 1918–1925. 27 indexed citations

18.

Rettinger, Eva, Hermann Kreyenberg, Andreas Volk, et al.. (2012). Cytotoxic Capacity of IL-15-Stimulated Cytokine-Induced Killer Cells Against Human Acute Myeloid Leukemia and Rhabdomyosarcoma in Humanized Preclinical Mouse Models. SHILAP Revista de lepidopterología. 2. 32–32. 35 indexed citations

19.

Rettinger, Eva, Selim Kuçi, P. S. A. Becker, et al.. (2011). The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells. Cytotherapy. 14(1). 91–103. 87 indexed citations

20.

Kuçi, Selim, Eva Rettinger, Gerrit Weber, et al.. (2010). Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation. Haematologica. 95(9). 1579–1586. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact